1-1 of 1
Pamela Levine
Close
Sort by
Journal Articles

Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression

Clinical Trials & Observations
Eric D. Jacobsen, Jeff P. Sharman, Yasuhiro Oki, Ranjana H. Advani, Jane N. Winter, Celeste M. Bello, Gary Spitzer, Maria Corinna Palanca-Wessels, Dana A. Kennedy, Pamela Levine, Jing Yang, Nancy L. Bartlett
Journal: Blood
Blood (2015) 125 (9): 1394–1402.
https://doi.org/10.1182/blood-2014-09-598763
Published: 2015
Includes: Supplemental data